In re Hogan

559 F.2d 595, 194 U.S.P.Q. (BNA) 527, 1977 CCPA LEXIS 125
CourtCourt of Customs and Patent Appeals
DecidedJuly 28, 1977
DocketPatent Appeal No. 76-641
StatusPublished
Cited by65 cases

This text of 559 F.2d 595 (In re Hogan) is published on Counsel Stack Legal Research, covering Court of Customs and Patent Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re Hogan, 559 F.2d 595, 194 U.S.P.Q. (BNA) 527, 1977 CCPA LEXIS 125 (ccpa 1977).

Opinions

MARKEY, Chief Judge.

This appeal is from the decision of the Patent and Trademark Office (PTO) Board of Appeals affirming various rejections, under 35 U.S.C. §§ 102, 103, 112 (first paragraph), and 132, of claims 13-15 in appellants’ application No. 181,185 filed September 16,1971 (the 1971 application) for “Solid Polymers of Olefins.”1 A main issue involves use of a “later state of the art” as evidence to support a rejection.

The 1971 application is said to be a continuation of application No. 648,364 filed June 23,1967 (the 1967 application), in turn a “divisional” of application No. 558,530 filed January 11, 1956 (the 1956 application)2. The 1956 application is a continuation-in-part of application No. 476,-306 filed December 20, 1954 and application No. 333,576 filed January 27, 1953 (the 1953 application).

We affirm in part, reverse in part, and remand with respect to certain rejections.

The Claims

Although the 1971 application discloses several polymers, the claims are limited:3

13. A normally solid homopolymer of 4-methyl-l-pentene.4
[598]*59814. A polymer of claim 13 having a melting point in the range of 390 to 425 °F.
15. A polymer of claim 13 which is wax-like and thermally stable as evidenced by substantially no decomposition at temperatures below about 700 °F. as shown by Figure 5.5

The Disclosures

Appellants assert that, under the provisions of 35 U.S.C. § 120,6 claims 13 and 15 are entitled to the benefit of the filing date of the 1953 application and claim 14 is entitled to the benefit of the filing date of the 1956 application.

The 1953 application discloses solid polymers made from 1-olefin monomers having a maximum chain length of eight carbon atoms and no branching nearer the double bond than the 4-position. Several olefin monomers which form such polymers are disclosed: ethylene, propylene, 1-butene, 1-pentene, 1-hexene, and 4-methyl-l-pentene.

A method of making such polymers using a catalyst containing chromium oxide on a silica-alumina support is described. The application includes twenty “examples” and twenty-five “tables” giving detailed information on: how to prepare, activate, use, and regenerate the catalyst; how to influence the molecular weight of the polymer products; what solvents or diluents to use in admixture with the olefin feed; what feed velocities, reaction pressures, reaction temperatures, and reaction times are operative; and certain physical and chemical characteristics of the polymer products.

Example I in the 1953 application includes this statement, which we designate as [A]:

[A]
4-Methyl-l-pentene gave tough, solid polymer which, however, was successfully expelled from the reactor in continuous-flow operation.

Example XVI refers to Figure 2 in the drawings, which is a graph showing thermal depolymerization curves for five polyolefin polymers and commercial polyisobutylene. Example XVI includes this statement, which we designate as [B]:

[B]
Whereas the former [commercial polyisobutylene] began to decompose at about 600 °F, the latter (polymers of propylene, 1-butene, 1-pentene, 1-hexene, and 4-me-thyl-l-pentene) began to decompose at about 700-725 °F.

Example XIX describes polymerizing 4-me-thyl-l-pentene “over chromia-alumina-silica catalyst” and states: “The 4-methyl-l-pen-tene polymer is a tough solid polymer suitable for a substitute for natural waxes.”

The 1956 application is a continuation-in-part application and as filed contains most, but not all, of the information found in the 1953 application. Missing from the 1956 application as filed are statement [B] and the graph of Figure 2. Included in the 1956 application are the following new statements not present in the 1953 application, which we designate as [C] and [D]:

[C]
We have produced crystalline polymers of 4-methyl-l-pentene which have melting points in the range of 390 to 425 °F.
IP]
1-Butene and 4-methyl-l-pentene can be polymerized in substantially the same manner as previously described and produce crystalline polymers. One sample of [599]*5994-methyl-l-pentene polymer thus obtained had a melting point of 394° to 421 °F. A second similar polymer of 4-methyl-l-pentene produced in the same general manner had a melting point of 410 to 420 °F.

The 1967 application, according to appellants’ brief before the board, contains all of the disclosures relating to polymers of 4-methyl-l-pentene contained in the 1953 and 1956 applications. The 1971 application on appeal contains statements [A] and [B], the Figure 2 graph (now Figure 5), and statements [C] and [D].

The following table summarizes the disclosures:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Arthrex, Inc. v. Smith & Nephew, Inc.
35 F.4th 1328 (Federal Circuit, 2022)
Amgen Inc. v. Sanofi
Federal Circuit, 2021
Abiomed, Inc. v. Maquet Cardiovascular LLC
329 F. Supp. 3d 1 (District of Columbia, 2018)
Amgen Inc. v. Sanofi, Aventisub LLC
872 F.3d 1367 (Federal Circuit, 2017)
Pfizer Inc. v. Teva Pharmaceuticals USA, Inc.
555 F. App'x 961 (Federal Circuit, 2014)
Disney Enterprises, Inc. v. Kappos
923 F. Supp. 2d 788 (E.D. Virginia, 2013)
Pfizer Inc. v. Teva Pharmaceuticals U.S.A., Inc.
882 F. Supp. 2d 643 (D. Delaware, 2012)
Loughlin v. Ling
684 F.3d 1289 (Federal Circuit, 2012)
Hollmer v. Harari
681 F.3d 1351 (Federal Circuit, 2012)
MAGSIL CORP. v. Seagate Technology
764 F. Supp. 2d 674 (D. Delaware, 2011)
Tafas v. Doll
559 F.3d 1345 (Federal Circuit, 2009)
Takeda Pharmaceutical Co., Ltd. v. Dudas
511 F. Supp. 2d 81 (District of Columbia, 2007)
Goss v. MAN Roland, et al.
2006 DNH 056 (D. New Hampshire, 2006)
Chiron Corporation v. Genentech, Inc., Defendant-Cross
363 F.3d 1247 (Federal Circuit, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
559 F.2d 595, 194 U.S.P.Q. (BNA) 527, 1977 CCPA LEXIS 125, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-hogan-ccpa-1977.